These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 20979799)
1. [A randomized, double-blind, placebo-control study of once-daily inhaled tiotropium in chronic obstructive pulmonary disease]. Yin KS; Zhang DP; Shi Y; Sun LH; Min R; Xiao YL; Xia XR; Tan Y; Fu WZ Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jul; 33(7):519-23. PubMed ID: 20979799 [TBL] [Abstract][Full Text] [Related]
2. [Comparison of tiotropium inhalation capsules and ipratropium metered dose inhaler in a randomized, double-blind, double-dummy, efficacy and safety study in patients with chronic obstructive pulmonary disease]. Zheng JP; Kang J; Cai BQ; Zhou X; Cao ZL; Bai CX; Zhong NS Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jun; 29(6):363-7. PubMed ID: 17045014 [TBL] [Abstract][Full Text] [Related]
3. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD. Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763 [TBL] [Abstract][Full Text] [Related]
4. [Efficacy of tiotropium bromide (Spiriva) in patients with chronic-obstructive pulmonary disease (COPD) of different severities]. Beeh KM; Beier J; Buhl R; Stark-Lorenzen P; Gerken F; Metzdorf N; Pneumologie; 2006 Jun; 60(6):341-6. PubMed ID: 16761228 [TBL] [Abstract][Full Text] [Related]
5. A randomized study of tiotropium Respimat Soft Mist inhaler vs. ipratropium pMDI in COPD. Voshaar T; Lapidus R; Maleki-Yazdi R; Timmer W; Rubin E; Lowe L; Bateman E Respir Med; 2008 Jan; 102(1):32-41. PubMed ID: 17996436 [TBL] [Abstract][Full Text] [Related]
6. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. Tashkin DP; Celli B; Senn S; Burkhart D; Kesten S; Menjoge S; Decramer M; N Engl J Med; 2008 Oct; 359(15):1543-54. PubMed ID: 18836213 [TBL] [Abstract][Full Text] [Related]
7. Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium. Donohue JF; Fogarty C; Lötvall J; Mahler DA; Worth H; Yorgancioglu A; Iqbal A; Swales J; Owen R; Higgins M; Kramer B; Am J Respir Crit Care Med; 2010 Jul; 182(2):155-62. PubMed ID: 20463178 [TBL] [Abstract][Full Text] [Related]
8. The efficacy of tiotropium administered via Respimat Soft Mist Inhaler or HandiHaler in COPD patients. van Noord JA; Cornelissen PJ; Aumann JL; Platz J; Mueller A; Fogarty C Respir Med; 2009 Jan; 103(1):22-9. PubMed ID: 19022642 [TBL] [Abstract][Full Text] [Related]
9. Absence of electrocardiographic findings and improved function with once-daily tiotropium in patients with chronic obstructive pulmonary disease. Covelli H; Bhattacharya S; Cassino C; Conoscenti C; Kesten S Pharmacotherapy; 2005 Dec; 25(12):1708-18. PubMed ID: 16305289 [TBL] [Abstract][Full Text] [Related]
11. Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: a placebo-controlled trial. Tashkin DP; Littner M; Andrews CP; Tomlinson L; Rinehart M; Denis-Mize K Respir Med; 2008 Apr; 102(4):479-87. PubMed ID: 18258423 [TBL] [Abstract][Full Text] [Related]
12. The effect of tiotropium on hyperinflation and exercise capacity in chronic obstructive pulmonary disease. Verkindre C; Bart F; Aguilaniu B; Fortin F; Guérin JC; Le Merre C; Iacono P; Huchon G Respiration; 2006; 73(4):420-7. PubMed ID: 16484769 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the efficacy and safety of tiotropium bromide (5 µg) inhaled via Respimat in Chinese patients with chronic obstructive pulmonary disease. Tang Y; Massey D; Zhong NS Chin Med J (Engl); 2013; 126(19):3603-7. PubMed ID: 24112149 [TBL] [Abstract][Full Text] [Related]
14. Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease. Littner MR; Ilowite JS; Tashkin DP; Friedman M; Serby CW; Menjoge SS; Witek TJ Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1136-42. PubMed ID: 10764302 [TBL] [Abstract][Full Text] [Related]
15. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group. Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576 [TBL] [Abstract][Full Text] [Related]
17. Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial. Kerstjens HA; Disse B; Schröder-Babo W; Bantje TA; Gahlemann M; Sigmund R; Engel M; van Noord JA J Allergy Clin Immunol; 2011 Aug; 128(2):308-14. PubMed ID: 21636120 [TBL] [Abstract][Full Text] [Related]
18. Tiotropium bromide: a new long-acting bronchodilator for the treatment of chronic obstructive pulmonary disease. Koumis T; Samuel S Clin Ther; 2005 Apr; 27(4):377-92. PubMed ID: 15922812 [TBL] [Abstract][Full Text] [Related]
19. Short-term effects of inhalative tiotropium/formoterol/budenoside versus tiotropium/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomized trial. Bölükbas S; Eberlein M; Eckhoff J; Schirren J Eur J Cardiothorac Surg; 2011 Jun; 39(6):995-1000. PubMed ID: 20970351 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of tiotropium in COPD patients from Asia: a subgroup analysis from the UPLIFT trial. Fukuchi Y; Fernandez L; Kuo HP; Mahayiddin A; Celli B; Decramer M; Kesten S; Liu D; Tashkin D Respirology; 2011 Jul; 16(5):825-35. PubMed ID: 21539680 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]